28Aug
27Aug
XYLYX BIO releases highly physiologic 2D substrates for improved antifibrotic drug discovery
New York-based Xylyx Bio, a leader in advanced disease models, today announced the release of normal and fibrotic NativeCoat™ human lung- and liver-specific ECM substrates for antifibrotic drug discovery to increase predictiveness of high throughput screening and improve evaluation of efficacy of biopharmaceutical drug candidates for hard to treat fibrotic diseases such as IPF and NASH. Read more >>
27Aug
Myomo® Extends and Strengthens its Global MyoPro™ Patent Portfolio
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced additional intellectual property protection with the issuance of new patents in the U.S. and Europe related to MyoPro™, its unique wearable robotic brace for arm and hand paralysis. Read more >>
26Aug
Framingham’s Rising Star
At 15, highschooler David Zamarin sold his cleaning company to invest in a new product idea leading to the founding of Framingham-based DetraPel (in comparison, at age 13, Bose Corporation's Amar Bose began repairing radio sets for pocket money for repair shops in Philadelphia.) DetraPel manufactures non-toxic fabric protectors that are gaining world-wide acclaim. Read more >>
26Aug
Grapefruit USA, Inc. Commences Production of Its Patented Disruptive Time Release Hourglass(TM) THC+CBD Delivery Cream
Grapefruit USA, Inc., a fully licensed California based cannabis company, is announcing today that it has commenced production of the Hourglass™ time release THC+CBD delivery cream at its manufacturing facility in the Coachillin Canna-Business Park in Desert Hot Springs, California, pursuant to its Exclusive License and Supply Agreement with Zylö Therapeutics Inc. Read more >>
26Aug
Wasabi Tripling As It Siphons Customers From AWS, Azure In $233 Billion Cloud Market
A case in point is Boston-based Wasabi Technologies, a provider of object storage services that compete with AWS’s S3 at 20% of the price. Whereas the industry grew at an average 31% rate in the most recent quarter, Wasabi’s revenues soared 5.5-fold between January 2019 and January 2020 and are expected to triple in 2020. Read more >>
21Aug
4th Annual IPF Summit
Xylyx Bio. to speak at the 4th Annual IPF Summer. Read more >>
21Aug
Pet Startups in Korea Providing Innovative Solutions – Best of 2020
Pet startups in Korea are on the rise because it is estimated that South Koreans spend $2.5 billion a year on their pets in 2019. The Korea Rural Economic Institute feels this number will double to $5 billion by 2027. Anubis Bio on list. Read more >>
21Aug
Myomo® Receives First Australian Insurance Authorization for MyoPro™
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that a Myomo-trained Orthotic & Prosthetic (“O&P”) practice in Australia has received its first insurance authorization to fit a patient with a custom MyoPro device. This is the first authorization following Myomo’s entry into Australia as part of its international expansion initiative. Read more >>
21Aug